Pentwater Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Pentwater Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-331,214	Closed	-$19.8M	–	188
2019 Q4	$19.8M	Buy	+331,214	New	+$12.4M	0.32%	49

Pentwater Capital Management's BOLD Position: Q1 2020 in Review

Pentwater Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 331,214 shares — an estimated $19.8M sold.

Pentwater Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $19.8M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Pentwater Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Pentwater Capital Management sold 331,214 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $19.8M.
Pentwater Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Pentwater Capital Management's Audentes Therapeutics, Inc position peaked at $19.8M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.